Estimating the prevalence of definitive chronic kidney disease in the Japanese general population

[1]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[2]  J. Kaufman,et al.  Age affects outcomes in chronic kidney disease. , 2007, Journal of the American Society of Nephrology : JASN.

[3]  P. Cockwell,et al.  The global burden of chronic kidney disease , 2020, The Lancet.

[4]  A. Rule,et al.  An Age-Calibrated Definition of Chronic Kidney Disease: Rationale and Benefits. , 2016, The Clinical biochemist. Reviews.

[5]  A. Rule,et al.  The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. , 2012, Kidney international.

[6]  H. Völzke,et al.  Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  Y. Kiyohara,et al.  Prevalence of chronic kidney disease in the Japanese general population , 2009, Clinical and Experimental Nephrology.

[8]  K. Iseki,et al.  Cause-specific mortality in the general population with transient dipstick-proteinuria , 2019, PloS one.

[9]  Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD , 2012, Kidney international supplements.

[10]  R. Glassock,et al.  An Age-Calibrated Classification of Chronic Kidney Disease. , 2015, JAMA.

[11]  M. D. de Broe,et al.  Epidemiology of chronic kidney disease: think (at least) twice! , 2017, Clinical kidney journal.

[12]  B. Eriksen,et al.  In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression. , 2007, Kidney international.

[13]  Chapter 1: Definition and classification of CKD , 2012, Kidney International Supplements.

[14]  J. Coresh,et al.  Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality. , 2017, Kidney international.

[15]  D. Warnock,et al.  The global burden of chronic kidney disease: estimates, variability and pitfalls , 2017, Nature Reviews Nephrology.